Delivery Order SPE2DB22D9101-SPE2DB24FU7NT

Award Date 9/18/24
Potential Completion Date 10/9/24
Potential Value $6K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Park Ridge, IL 60068, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award is for the delivery of the pharmaceutical product Kyleena, a 19.5 mg intrauterine contraceptive system, to the Defense Logistics Agency (DLA). The contract, valued at $9,341.92, was awarded to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. This delivery order contract is part of a larger indefinite delivery contract (IDC) valued at up to $499,999,999 held by DMS Pharmaceutical Group with the DLA under the SPE2DB program. The...
This federal contract award is for the delivery of the pharmaceutical product Kyleena, a 19.5 mg intrauterine system, to the Defense Logistics Agency (DLA). The contract, valued at $1,805.79, was awarded to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. DMS Pharmaceutical Group Inc. holds a significant indefinite delivery contract (IDC) with the DLA under the SPE2DB program, valued at up to $499,999,999, which runs through...
This federal contract award is to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, valued at $1,814.82, was awarded by the Defense Logistics Agency (DLA) under the Medical Supply Chain division. It is a delivery order contract for the supply of pharmaceutical products, including the Kyleena 19.5 mg intrauterine contraceptive system. The contract has a firm fixed-price pricing type and a completion date of June...
This federal contract award was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $3,009.65 firm fixed-price delivery order is for the supply of the Kyleena 19.5 mg intrauterine system contraceptive device. This award is part of a larger indefinite delivery contract (IDC) valued at up to $499,999,999 that DMS Pharmaceutical Group holds with the DLA under the SPE2DB program,...
The federal contract award with ID SPE2DX15D9628|SPE2DX24FKVYY was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $2,419.76 firm fixed-price delivery order contract is for the supply of a pharmaceutical product, specifically the Kyleena 19.5mg intrauterine system. This award is part of DMS Pharmaceutical Group's larger indefinite delivery contract (IDC) with the DLA, valued...
This federal contract award, valued at $7,041.60, was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is for the delivery of Kyleena 19.5 mg intrauterine contraceptive systems and has a performance period ending on May 23, 2024. The contract is a firm fixed-price delivery order and does not have a set-aside designation. DMS Pharmaceutical Group Inc. holds a...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract worth $1,149.40 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is for the delivery of 4564814368 Kyleena 19.5 mg systems, a contraceptive device. This award is part of a larger Indefinite Delivery Contract (IDC) with DMS Pharmaceutical Group worth up to $499,999,999, which enables the DLA to issue firm fixed-price...
This federal contract award was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler located in Park Ridge, Illinois. The $4,478.32 firm fixed-price delivery order contract covers the supply of the Kyleena 19.5 mg intrauterine contraceptive system to support the medical needs of military healthcare facilities. DMS Pharmaceutical Group holds a $499,999,999 Indefinite Delivery Contract (IDC) with the DLA under the...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract valued at $1,171.86 to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. The contract is for the delivery of the pharmaceutical product Kyleena 19.5 mg systems. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at $499,999,999 that DMS Pharmaceutical Group holds with the DLA under the SPE2DB program. The IDC allows the DLA to issue...
This federal contract award was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $5,838.70 firm fixed-price delivery order is for the supply of Kyleena 19.5 mg intrauterine contraceptive systems to support the medical needs of military healthcare facilities. DMS Pharmaceutical Group holds a $499,999,999 Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program,...
  • SPE2DB22D9101
    Indefinite Delivery Contract
  • SPE2DB22D9101-SPE2DB24FU7NT
    Delivery Order

This federal contract award is for the delivery of pharmaceutical products, specifically the Kyleena intrauterine contraceptive system, to the Defense Logistics Agency (DLA), a defense agency. The contract, valued at $6,019.30, is a firm fixed-price delivery order awarded to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. The contract has an ultimate completion date of October 9, 2024.

DMS Pharmaceutical Group Inc. holds a significant indefinite delivery contract (IDC) with the DLA under the SPE2DB program, valued at up to $499,999,999, which runs through December 31, 2025. This single-award IDC allows the DLA to issue firm fixed-price delivery orders for a comprehensive range of pharmaceutical items to fulfill the recurring medical supply needs of military health facilities worldwide. The contract does not have a set-aside designation.

Generated 12/18/24, 9:34 AM